Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Journal of comparative effectiveness research

Showing results (81-90 of 1,446) with videos related to

Pageof 145
Sort By:
Journal of Comparative Effectiveness Research|May 21, 2025
Cost-effectiveness and budget impact analysis of switching from apixaban to rivaroxaban treatment among patients with nonvalvular atrial fibrillation in a German healthcare settingRupesh Subash, Thomas Strakosch, Michelle Zhang, et al.
Journal of Comparative Effectiveness Research|May 9, 2025
Overall survival in patients with metastatic castration-sensitive prostate cancer treated with apalutamide versus abiraterone acetate: a head-to-head analysis of real-world patients in the USABenjamin Lowentritt, Mehmet A Bilen, Ibrahim Khilfeh, et al.
Journal of Comparative Effectiveness Research|February 9, 2026
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 24Paul Arora, Sreeram V Ramagopalan
Journal of Comparative Effectiveness Research|January 27, 2026
First-line tumor necrosis factor inhibitor versus abatacept treatment choice in real-world patients with anticitrullinated protein antibody- and rheumatoid factor-positive rheumatoid arthritisGordon Lam, Hanke Zheng, Andrew Klink, et al.
Journal of Comparative Effectiveness Research|March 17, 2025
Trends in adoption of knotless tissue control devices in robotic surgeryBarbara H Johnson, Sinchana T, Stephen S Johnston, et al.
Journal of Comparative Effectiveness Research|February 23, 2013
Insights from a conference on implementing comparative effectiveness research through shared decision-makingMary C Politi, Marla L Clayman, Angela Fagerlin, et al.
Journal of Comparative Effectiveness Research|November 18, 2017
Treatment patterns of biologics in US patients with ankylosing spondylitis: descriptive analyses from a claims databaseJessica A Walsh, Oluwakayode Adejoro, Benjamin Chastek, et al.
Journal of Comparative Effectiveness Research|November 18, 2017
Patient and provider perspectives on shared decision making: a systematic review of the peer-reviewed literatureNyna Williams, Chris Fleming, Annie Doubleday
Journal of Comparative Effectiveness Research|November 18, 2017
Effectiveness and safety of anti-ischemic trimetazidine in patients with stable angina pectoris and Type 2 diabetesZsófia Meiszterics, Attila Kónyi, Gábor Hild, et al.
Journal of Comparative Effectiveness Research|March 29, 2018
Analysis of indirect treatment comparisons in national health technology assessments and requirements for industry submissionsIscha J Es-Skali, John Spoors
Pageof 145

Showing results (81-90 of 1,446) with videos related to

Sort By:
Pageof 145
Journal of Comparative Effectiveness Research|May 21, 2025
Cost-effectiveness and budget impact analysis of switching from apixaban to rivaroxaban treatment among patients with nonvalvular atrial fibrillation in a German healthcare settingRupesh Subash, Thomas Strakosch, Michelle Zhang, et al.
Journal of Comparative Effectiveness Research|May 9, 2025
Overall survival in patients with metastatic castration-sensitive prostate cancer treated with apalutamide versus abiraterone acetate: a head-to-head analysis of real-world patients in the USABenjamin Lowentritt, Mehmet A Bilen, Ibrahim Khilfeh, et al.
Journal of Comparative Effectiveness Research|February 9, 2026
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 24Paul Arora, Sreeram V Ramagopalan
Journal of Comparative Effectiveness Research|January 27, 2026
First-line tumor necrosis factor inhibitor versus abatacept treatment choice in real-world patients with anticitrullinated protein antibody- and rheumatoid factor-positive rheumatoid arthritisGordon Lam, Hanke Zheng, Andrew Klink, et al.
Journal of Comparative Effectiveness Research|March 17, 2025
Trends in adoption of knotless tissue control devices in robotic surgeryBarbara H Johnson, Sinchana T, Stephen S Johnston, et al.
Journal of Comparative Effectiveness Research|February 23, 2013
Insights from a conference on implementing comparative effectiveness research through shared decision-makingMary C Politi, Marla L Clayman, Angela Fagerlin, et al.
Journal of Comparative Effectiveness Research|November 18, 2017
Treatment patterns of biologics in US patients with ankylosing spondylitis: descriptive analyses from a claims databaseJessica A Walsh, Oluwakayode Adejoro, Benjamin Chastek, et al.
Journal of Comparative Effectiveness Research|November 18, 2017
Patient and provider perspectives on shared decision making: a systematic review of the peer-reviewed literatureNyna Williams, Chris Fleming, Annie Doubleday
Journal of Comparative Effectiveness Research|November 18, 2017
Effectiveness and safety of anti-ischemic trimetazidine in patients with stable angina pectoris and Type 2 diabetesZsófia Meiszterics, Attila Kónyi, Gábor Hild, et al.
Journal of Comparative Effectiveness Research|March 29, 2018
Analysis of indirect treatment comparisons in national health technology assessments and requirements for industry submissionsIscha J Es-Skali, John Spoors
Pageof 145